These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15146426)

  • 41. The killer immunoglobulin-like receptor (KIR) group A haplotype is associated with bronchiolitis obliterans syndrome after lung transplantation.
    Kwakkel-van Erp JM; van de Graaf EA; Paantjens AW; van Ginkel WG; Schellekens J; van Kessel DA; van den Bosch JM; Otten HG
    J Heart Lung Transplant; 2008 Sep; 27(9):995-1001. PubMed ID: 18765192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding.
    Ramos-Lopez E; Scholten F; Aminkeng F; Wild C; Kalhes H; Seidl C; Tonn T; Van der Auwera B; Badenhoop K
    Tissue Antigens; 2009 Jun; 73(6):599-603. PubMed ID: 19392800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris.
    Suzuki Y; Hamamoto Y; Ogasawara Y; Ishikawa K; Yoshikawa Y; Sasazuki T; Muto M
    J Invest Dermatol; 2004 May; 122(5):1133-6. PubMed ID: 15140215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. KIR matching in hematopoietic stem cell transplantation.
    Bignon JD; Gagne K
    Curr Opin Immunol; 2005 Oct; 17(5):553-9. PubMed ID: 16085405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of inhibitory-motif killer immunoglobulin-like receptor, KIR2DL1, is increased in natural killer cells from women with pelvic endometriosis.
    Matsuoka S; Maeda N; Izumiya C; Yamashita C; Nishimori Y; Fukaya T
    Am J Reprod Immunol; 2005 May; 53(5):249-54. PubMed ID: 15833103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions.
    Pascal V; Schleinitz N; Brunet C; Ravet S; Bonnet E; Lafarge X; Touinssi M; Reviron D; Viallard JF; Moreau JF; Déchanet-Merville J; Blanco P; Harlé JR; Sampol J; Vivier E; Dignat-George F; Paul P
    Eur J Immunol; 2004 Oct; 34(10):2930-40. PubMed ID: 15368309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.
    Faridi RM; Das V; Tripthi G; Talwar S; Parveen F; Agrawal S
    Hum Reprod; 2009 Jul; 24(7):1758-64. PubMed ID: 19279038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of killer-cell immunoglobulin-like receptor (KIR) in Comoros and Southeast France.
    Frassati C; Touinssi M; Picard C; Segura M; Galicher V; Papa K; Gagne K; Vivier E; Degioanni A; Böetsch G; Mercier P; Vély F; de Micco P; Reviron D; Chiaroni J
    Tissue Antigens; 2006 May; 67(5):356-67. PubMed ID: 16671942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The presence of KIR2DS5 confers protection against adult immune thrombocytopenia.
    Seymour LA; Nourse JP; Crooks P; Wockner L; Bird R; Tran H; Gandhi MK
    Tissue Antigens; 2014 Mar; 83(3):154-60. PubMed ID: 24571473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis.
    Yen JH; Moore BE; Nakajima T; Scholl D; Schaid DJ; Weyand CM; Goronzy JJ
    J Exp Med; 2001 May; 193(10):1159-67. PubMed ID: 11369787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion.
    Denis L; Sivula J; Gourraud PA; Kerdudou N; Chout R; Ricard C; Moisan JP; Gagne K; Partanen J; Bignon JD
    Tissue Antigens; 2005 Oct; 66(4):267-76. PubMed ID: 16185321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of killer cell immunoglobulin-like receptor gene diversity III. KIR2DL3.
    Keaney L; Williams F; Meenagh A; Sleator C; Middleton D
    Tissue Antigens; 2004 Aug; 64(2):188-94. PubMed ID: 15245374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic analysis of a highly homologous gene family. The killer cell immunoglobulin-like receptors.
    Wilson MJ; Torkar M; Trowsdale J
    Methods Mol Biol; 2000; 121():251-63. PubMed ID: 10818731
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypothetical soluble KIR2DS4 natural killer cell receptor molecule does not associate with successful ageing in the Irish.
    Ross OA; Maxwell LD; Rea IM; Curran MD
    Exp Gerontol; 2004 May; 39(5):801-5. PubMed ID: 15130674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j).
    Saulquin X; Gastinel LN; Vivier E
    J Exp Med; 2003 Apr; 197(7):933-8. PubMed ID: 12668644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human single-chain Fv fragments specific for natural killer cell receptors from phage display libraries.
    Uchanska-Ziegler B; Qiao X; Volz A; Nissim A; Ziegler A
    Methods Mol Biol; 2000; 121():219-37. PubMed ID: 10818729
    [No Abstract]   [Full Text] [Related]  

  • 59. KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.
    Velarde-de la Cruz EE; Sánchez-Hernández PE; Muñoz-Valle JF; Palafox-Sánchez CA; Ramírez-de Los Santos S; Graciano-Machuca O; García-Iglesias T; Montoya-Buelna M; Ramírez-Dueñas MG
    Immunopharmacol Immunotoxicol; 2016 Aug; 38(4):303-9. PubMed ID: 27251940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel antibody combination to identify KIR2DS2
    Blunt MD; Rettman P; Bastidas-Legarda LY; Fulton R; Capizzuto V; Naiyer MM; Traherne JA; Khakoo SI
    HLA; 2019 Jan; 93(1):32-35. PubMed ID: 30381896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.